OriginCell
Pudong · Founded 2014
About OriginCell
OriginCell is a biomedical equipment enterprise that develops tumor immuno-therapy solutions. It develops tumor therapies and cellular drugs through the use of the 10-phage display library, humanized antibody technology platform, and antibody discovery platform that enable their medical facilities to apply in cancer treatments. OriginCell was founded in 2014 and is headquartered in Shanghai, China.
Company Facts
- Founded: 2014
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $197.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2022)
- Website: origincell-auto.com
- Phone: +86 021 6839 5577
Industries & Categories
Biopharma, Biotechnology, Medical, Medical Device
Canonical: https://fsome.com/organization/origincell-15970 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.